Trials / Completed
CompletedNCT02271529
Zilver PTX Delivery System
Zilver Paclitaxel(PTX) Thumbwheel Delivery System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zilver® PTX® Drug-Eluting Peripheral Stent | Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-10-22
- Last updated
- 2016-02-26
- Results posted
- 2016-02-26
Locations
6 sites across 3 countries: Australia, Germany, New Zealand
Source: ClinicalTrials.gov record NCT02271529. Inclusion in this directory is not an endorsement.